Jul 3, 2026 06:10PM
Jun 26, 2026 06:29PM
Mar 30, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM Appili Therapeutics raises C$177,500 in first tranche of private placement
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM
Nov 5, 2025 07:16AM
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM
Oct 1, 2025 07:17AM Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM
Sep 9, 2025 07:20AM
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
May 20, 2025 10:17AM
Apr 28, 2025 07:41AM Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 2, 2025 08:17AM
Apr 2, 2025 08:15AM
Mar 24, 2025 08:15AM
Mar 18, 2025 07:22AM
Mar 17, 2025 08:15AM Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025
Mar 6, 2025 08:15AM
Mar 6, 2025 08:15AM
Feb 14, 2025 05:06PM
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Oct 28, 2024 08:15AM
Oct 21, 2024 08:15AM
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM
Oct 8, 2024 08:15AM
Oct 3, 2024 08:15AM Aditxt Delivers Shareholder Update and 2024 Year-End Plan
Sep 24, 2024 08:15AM
Sep 20, 2024 08:15AM
Sep 17, 2024 05:11PM
Sep 9, 2024 08:15AM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM
Jun 25, 2024 05:46PM Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results
Apr 2, 2024 08:30AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All